Farmer James P, Lamba Manisha, Merkur Andrew B, Lamba Wiplove R, Hodge William G, Jordan David R, Sengar Dharmendra P S, Burns Bruce F
Department of Pathology, University of Ottawa, ON, Canada.
Can J Ophthalmol. 2006 Dec;41(6):753-60. doi: 10.3129/i06-071.
Conjunctival lymphoproliferative lesions have not been selected for independent analysis with newer immunohistochemical and molecular genetic techniques to highlight their unique profile.
Retrospective case series examined biopsies from 16 consecutive patients with conjunctival lymphoproliferative lesions. The histopathologic, immunohistochemical, and molecular genetic features were characterized, as well as the frequency of tumour type, prognostic implications, clinical features, and treatments offered.
The diagnosis was lymphoma in 12 cases, atypical lymphoid hyperplasia (ALH) in 1 case, and reactive lymphoid hyperplasia (RLH) in 3 cases. The primary lymphomas consisted of 4 mucosa-associated lymphoid tissue lymphomas (MALTL), 1 follicular lymphoma (FL), 2 diffuse large B-cell lymphomas (DLBCLs), 1 lymphoplasmacytic lymphoma, and 1 T-cell lymphoma. Primary lymphomas were treated with radiation (n = 7), surgery (n = 1), and topical chemotherapy (n = 1). Complete remission was achieved in 8 of 9 primary lymphomas. Two cases of recurrence to the other conjunctiva were treated with radiation and both remained disease free. Secondary lymphomas included 2 DLBCL and 1 MALTL. Complete remission was seen in 2 patients after radiation plus chemotherapy, while the patient treated with chemotherapy alone was lost to follow-up. The 1 case of ALH presented bilaterally and achieved complete remission after topical chemotherapy treatments. The 3 RLH cases were surgically managed and 2 of the 3 recurred and were subsequently excised. Eleven lymphomas were of B-cell lineage by immunophenotyping. Molecular genetic studies of immunoglobulin heavy chain (IgH) gene rearrangement by polymerase chain reaction (PCR) showed clonal bands in 6 of 12 lymphomas, 1 of 3 RLH (polyclonal by immunophenotyping) and 1 ALH. BCL2-IgH [t(14;18)] rearrangement was seen in 8 of 12 cases (1 FL, 3 DLBCLs, 4 MALTLs) by real-time quantitative PCR.
Conjunctival lymphomas are predominantly B-cell type with a high prevalence of MALTL. An unexpected finding was the BCL2-IgH rearrangement seen in 4 of 5 MALTL cases in our series. The significance of this remains unclear.
结膜淋巴增殖性病变尚未被选用更新的免疫组织化学和分子遗传学技术进行独立分析,以突出其独特特征。
回顾性病例系列研究了16例连续的结膜淋巴增殖性病变患者的活检标本。对其组织病理学、免疫组织化学和分子遗传学特征进行了描述,以及肿瘤类型的频率、预后意义、临床特征和所采用的治疗方法。
诊断为淋巴瘤12例,非典型淋巴样增生(ALH)1例,反应性淋巴样增生(RLH)3例。原发性淋巴瘤包括4例黏膜相关淋巴组织淋巴瘤(MALTL)、1例滤泡性淋巴瘤(FL)、2例弥漫性大B细胞淋巴瘤(DLBCL)、1例淋巴浆细胞淋巴瘤和1例T细胞淋巴瘤。原发性淋巴瘤的治疗方法为放疗(n = 7)、手术(n = 1)和局部化疗(n = 1)。9例原发性淋巴瘤中有8例实现完全缓解。2例复发至另一只结膜的患者接受了放疗,均无疾病复发。继发性淋巴瘤包括2例DLBCL和1例MALTL。2例患者在放疗加化疗后实现完全缓解,而仅接受化疗的患者失访。1例ALH患者双侧发病,局部化疗后实现完全缓解。3例RLH患者接受了手术治疗,其中2例复发,随后再次切除。免疫表型分析显示11例淋巴瘤为B细胞系。通过聚合酶链反应(PCR)对免疫球蛋白重链(IgH)基因重排进行分子遗传学研究,结果显示12例淋巴瘤中有6例出现克隆条带,3例RLH中有1例(免疫表型为多克隆)和1例ALH出现克隆条带。通过实时定量PCR检测,12例病例中有8例(1例FL、3例DLBCL、4例MALTL)出现BCL2-IgH [t(14;18)]重排。
结膜淋巴瘤主要为B细胞型,MALTL的患病率较高。一个意外发现是在我们的系列研究中,5例MALTL病例中有4例出现BCL2-IgH重排。其意义尚不清楚。